Dec 15 (Reuters) - Shares of French pharmaceutical group Sanofi fell 4% on Monday after it flagged another delay to a U.S.

A mom was overjoyed when she learned a gene therapy treatment could save her child's life, until she found out no one would ...

Medical experts are concerned that a panel discussion convened by the Food and Drug Administration could lead to more cases ...

On Friday, the F.D.A. approved a new antibiotic, zoliflodacin, a day after an article published in The Lancet reported that a ...

Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program ...

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

The FDA has proposed adding bemotrizinol, a new sunscreen ingredient, to the U.S. approval list, which could expand consumer ...

Pro-life groups are holding the U.S. Food and Drug Administration and its commissioner Marty Makary accountable for leaving ...

Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, said Johnson has “acted ...

Sanofi’s experimental multiple sclerosis drug got hit with two setbacks on Monday: a regulatory delay in the US as well as a failure in a late-stage clinical trial.

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

IL, and U.S. Rep. Rosa DeLauro, D-CT, have reintroduced the Federal Food Administration Act. The act is designed to ...